Valeant Pharmaceuticals International
(NYSE:VRX)|
22.17 +0.26 (1.19%) Jan 08 - Close |
|
|
|
Pre-Market 22.15 -0.02 (-0.09%) Thu, 8 Jan 2009 7:40 PM
- Compare VRX with:
- View: Line | Candlestick
Company Profile
Valeant Pharmaceuticals International
One Enterprise
Aliso Viejo, CA 92656
United States - Map
Phone: (949) 461-6000
Fax: (949) 461-6609
Website: www.valeant.com
State of incorporation: Delaware
CEO: J. Michael Pearson
Employees: 3,001
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Other
Mfr specialty & generic pharmaceutical products
A pharmaceutical company, which develops, manufactures and markets a range of pharmaceutical products, in the areas of neurology, infectious disease and dermatology.
Recent news for VRX
-
VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online - Jan 06 at 3:31 ET
-
Valeant Pharmaceuticals Appoints Chief Operating Officer of Specialty Pharmaceuticals
PR Newswire - Jan 06 at 8:00 ET
-
EDGAR Online - Jan 05 at 4:52 ET
-
Valeant closes on Dow Pharmaceutical Sciences
bizjournals.com - Jan 02 at 2:05 ET
-
Valeant closes Dow Pharmaceutical buyout
AP - Jan 02 at 9:43 ET
-
Valeant Pharmaceuticals Completes Acquisition of Dow Pharmaceutical Sciences, Inc.
PR Newswire - Jan 02 at 8:00 ET
-
Motley Fool - Dec 30 2008 at 11:19 ET
-
Valeant Pharmaceuticals to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
PR Newswire - Dec 24 2008 at 8:00 ET
-
Best CEOs Braved a Brutal Year
The Wall Street Journal Online - Dec 21 2008 at 11:48 ET
-
Who Are the Best CEOs of 2008?
The Wall Street Journal Online - Dec 16 2008 at 3:46 ET
Member sentiment (?) Neutral
Top members owning VRX
-
Top 37%
+2.61%
-
Top 10%
+10.34%
-
Top 34%
+3.04%
* Average monthly return vs. S&P 500